Physician Assistant · Winston Salem, NC
NPI
1477114585
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
Medical Center Blvd
Winston Salem, NC, 27157
Phone (336) 716-2255
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,334
138 services
Medicare patients, 2024
70
Average age 73
Drug cost, 2024
$6.8M
919 prescriptions
Company payments, 2024
$269
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura M Welsh was code 99214 (office e&m - established), 115 times for 65 patients. In total Laura M Welsh billed 138 services in 11 codes, and Medicare paid $7,334.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 115 | 65 | $57.39 | $6,600 |
By year: 2022 $5,186 for 86 services; 2023 $8,249 for 136 services; 2024 $7,334 for 138 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura M Welsh prescribed most often to Medicare patients was Allopurinol, with 104 prescriptions and refills. In total Laura M Welsh wrote 919 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 104 | 223 | 28 | $972 |
| Imbruvica Ibrutinib | 99 | 99 | Under 11 | $1.6M |
| Calquence Acalabrutinib Maleate | 68 | 68 | Under 11 | $896K |
| Venclexta Venetoclax | 62 | 63 | 17 | $637K |
| Sprycel Dasatinib | 38 | 38 | Under 11 | $529K |
| Imatinib Mesylate Generic | 37 | 37 | Under 11 | $7,801 |
| Acyclovir Generic | 33 | 54 | Under 11 | $358 |
| Tasigna Nilotinib Hcl | 30 | 30 | Under 11 | $422K |
| Bosulif Bosutinib | 29 | 29 | Under 11 | $439K |
| Scemblix Asciminib Hydrochloride | 25 | 25 | Under 11 | $527K |
| Jakafi Ruxolitinib Phosphate | 25 | 25 | Under 11 | $359K |
| Fluconazole Generic | 23 | 23 | Under 11 | $461 |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $281K |
| Levofloxacin Generic | 18 | 18 | Under 11 | $385 |
| Hydroxyurea Generic | 17 | 51 | Under 11 | $675 |
Brand drugs: 468 claims; generic drugs: 451 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Laura M Welsh $269 ($269 in general payments such as food, travel and fees) from 3 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.